K(+)-evoked [(3)H]-norepinephrine release in human brain slices from epileptic and non-epileptic patients is differentially modulated by gabapentin and pinacidil

Neurosci Res. 2006 Jun;55(2):204-10. doi: 10.1016/j.neures.2006.01.007. Epub 2006 May 2.

Abstract

The modulation of K(+)-evoked [(3)H]-norepinephrine ([(3)H]-NE) release by gabapentin (GBP) and pinacidil (PIN), a known K(ATP) agonist, was examined in human brain slices. We compared the pharmacological effects on NE-release in human epileptic neocortex and epileptic hippocampus to non-epileptic neocortex. GBP (100 microM) decreased [(3)H]-NE release by 22% in non-epileptic neocortical slices, whereas this inhibition was absent in slices from epileptic hippocampus and epileptic neocortex. PIN (10 microM) also reduced [(3)H]-NE release by 30% in non-epileptic neocortical slices and only by 5% in epileptic hippocampal slices. The blockade of voltage-gated calcium channels by omega-conotoxins MVIIA and MVIIC (0.1 microM) reduced [(3)H]-NE release in epileptic and non-epileptic neocortical slices to the same extend. The data show a marked reduction in K(+)-evoked [(3)H]-NE release by GBP and PIN in epileptic hippocampus and neocortex, suggesting an alteration of K(ATP) channel function, whereas the effects of the calcium channel modulators omega-conotoxins MVIIA and MVIIC are similar in both epileptic and non-epileptic neocortex.

Publication types

  • Comparative Study
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adrenergic alpha-Agonists / pharmacology
  • Adult
  • Aged
  • Amines / pharmacology*
  • Anticonvulsants / pharmacology*
  • Brimonidine Tartrate
  • Calcium Channel Blockers / pharmacology
  • Child
  • Cyclohexanecarboxylic Acids / pharmacology*
  • Epilepsy / pathology*
  • Female
  • Gabapentin
  • Hippocampus / drug effects*
  • Humans
  • Idazoxan / pharmacology
  • In Vitro Techniques
  • Male
  • Middle Aged
  • Norepinephrine / metabolism*
  • Pinacidil / pharmacology*
  • Potassium / pharmacology
  • Quinoxalines / pharmacology
  • Time Factors
  • Tritium / metabolism
  • gamma-Aminobutyric Acid / pharmacology*
  • omega-Conotoxins / pharmacology

Substances

  • Adrenergic alpha-Agonists
  • Amines
  • Anticonvulsants
  • Calcium Channel Blockers
  • Cyclohexanecarboxylic Acids
  • Quinoxalines
  • omega-Conotoxins
  • Tritium
  • Brimonidine Tartrate
  • gamma-Aminobutyric Acid
  • Gabapentin
  • Pinacidil
  • Potassium
  • Norepinephrine
  • Idazoxan